Active form of prodrug: Melphalan [DR:D00369]
Treatment of multiple myeloma
Target
DNA
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01A ALKYLATING AGENTS
L01AA Nitrogen mustard analogues
L01AA10 Melphalan flufenamide
D11870 Melphalan flufenamide hydrochloride (USAN)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11870
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D11870
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11870